Novel HER2 Drug Shrinks Lung Cancer Tumors in Early Trial

By News Health
6 hours Ago

(MedPage Today) — BERLIN — An investigational oral drug currently under review with the FDA showed durable antitumor activity in patients with HER2-mutant advanced non-small cell lung cancer (NSCLC), findings from an international phase I/II…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118084

Author :

Publish date : 2025-10-22 17:31:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Bad Gums Tied to Big Brain Risks

Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer

'Alternative' to CDC's Flagship Journal in the Works

Can Steroids Be Stopped in Lupus Nephritis? Yes, and Here's How

A Peek Inside the Blue Medical Tent That Has Become a Fixture on NFL Sidelines

Ob/Gyns Urged to Fight Contraception Misinformation